INS and type 2 diabetes mellitus: By tracking nearly all insulin purchases and diagnoses from primary and specialty care, we could reliably assess demographic data to support accurate T1D/T2D classification and evaluate patterns in insulin use, which remains unique to our study to the best of our knowledge.